Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17α-substituted analogs of δ(9(11))- dehydro-17β-estradiol

Steroids

Volumn 62, Issue 11, 1997, Pages 688-694

  Römer, Wolfgang ^a   Oettel, Michael ^a   Menzenbach, Bernd ^a   Droescher, Peter ^a   Schwarz, Sigfrid ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

(9(11)) dehydro 17 estradiol; Antioxidative effect; Estrogen with 17 side chain; Iron redox chemistry; Lipid peroxidation; Superoxide anion radical

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BUTYLCRESOL; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTROGEN DERIVATIVE; J 1213; J 843; J 844; J 864; J 872; J 897; J 898; N,N DIMETHYLANILINE; PARA CRESOL; PROBUCOL; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ESTROGEN SYNTHESIS; IRON CHELATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANISOLES; ANTIOXIDANTS; CHEMILUMINESCENT MEASUREMENTS; CRESOLS; ESTRADIOL; FERRIC COMPOUNDS; FERROUS COMPOUNDS; FREE RADICAL SCAVENGERS; IRON CHELATING AGENTS; LIPID PEROXIDATION; MALE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES; SUPEROXIDES; SYNAPTOSOMES; TOLUIDINES; XANTHINE; XANTHINE OXIDASE;

EID: 0342275215     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(97)00068-8     Document Type: Article

References (27)

1. Samsioe G (1994). Cardioprotection by estrogens: mechanisms of action-the lipids. Int J Fertil 39 (Suppl. 1):43-49.
2. Lufkin EG, Ory SJ (1995). Postmenopausal estrogen therapy, 1995. Trends Endocrinol Metab 6:50-54.
3. Wilcox JG, Hwang J, Hodis HN, Sevanian A, Stanczyk FZ, Lobo RA (1997). Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil Steril 67:57-62.
4. Adams MR, Washburn SA, Wagner JD, Williams JK, Clarkson TB (1994). Arterial changes. Estrogen deficiency and effects of hormone replacement. In: Lobo RA (ed), Treatment of the Postmenopausal Woman. Basic and Clinical Aspects. Raven Press, New York, pp. 243-250.
5. Barrett-Connor E (1996). The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence. Maturitas 23:227-234.
6. Guetta V, Cannon III RO (1996). Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 93:1928-1937.
7. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK (1997). Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17:217-221.
8. Ditkoff EC, Crary WG, Christo M, Lobo RA (1991). Estrogen improves psychological functioning in asymptomatic postmenopausal women. Obstet Gynecol 78:991-995.
9. Sherwin BB (1996). Effective changes with estrogen and androgen replacement therapy in surgically menopausal women. Obstet Gynecol 14:177-187.
10. Aruoma OI (1996). Characterization of drugs as antioxidant prophylactics. Free Rad Biol Med 20:675-705.
11. Bhavnani BR (1988). The saga of ring B unsaturated equine estrogens. Endocr Rev 9:396-416.
12. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z (1993). Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metabol 77:1095-1097.
13. Tang M, Abplanalp W, Ayres S, Subbiah MTR (1996). Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 45:411-414.
14. Washburn SA, Honore EK, Cline JM, Helman M, Wagner JD, Adams MR, Adelman SJ, Clarkson TB (1996). Effects of 17α-dihydroequilenin sulfate on atherosclerotic male and female rhesus monkeys. Am J Obstet Gynecol 175:341-341.
15. 8.9-dehydro derivatives of 17α-estradiol and 17β-estradiol. Steroids 62:304-310.
16. Cynshi O, Takashima Y, Katoh Y, Tamura K (1995). Action of phenolic antioxidants on various active oxygen species. J Biolumin Chemilumin 10:261-269.
17. Kitagawa S, Fujisawa H, Sakurai H (1992). Scavenging effects of dihydric and polyhydric phenols on superoxide anion radicals, studied by electron spin resonance spectrometry. Chem Pharm Bull 40:304-307.
18. Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED (1989). The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14:141-152.
19. Buege A, Aust SD (1978). Microsomal lipid peroxidation. Methods Enzymol 52:302-310.
20. Ruiz-Larrea B, Leal A, Martin C, Martinez R, Lacort M (1995). Effects of estrogens on the redox chemistry of iron: A possible mechanism of the antioxidant action of estrogens. Steroids 60:780-783.
21. Laihia JK, Jansen CT, Ahotupa M (1993). Lucigenin and linoleate enhanced chemiluminescent assay for superoxide dismutase activity. Free Rad Biol Med 14:457-461.
22. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407-412.
23. Wagner JD, Washburn SA, Zhang L, Honore EK, Williams JK, Schwenke C (1995). A non-feminizing conjugated equine estrogen decreases arterial LDL degradation and improves vascular reactivity in male rhesus monkeys. Circulation 92:1-627.
24. Wilcox JG, Hodis HN, Sevanian A, Stanczyk FZ, Lobo RA (1995). The biological effects of individual estrogen components in conjugated equine estrogens (CEE) and their possible modulation of insulin resistance and oxidation of LDL. J Soc Gynecol Invest 2:153.
25. Marciniak G, Petty MA (1996). Design and biological evaluation of new antioxidants for use in cerebrovascular disorders. Drugs Future 21:1037-1046.
26. Bhavnani BR (1981). Estrogen biosynthesis in the pregnant mare. J Endocrinol 89:19P-32P.
27. Miller DM, Grover TA, Nayni N, Aust SA (1993). Xanthine oxidase- and iron-dependent lipid peroxidation. Arch Biochem Biophys 301:1-7.